David Schuller

800 total citations
19 papers, 630 citations indexed

About

David Schuller is a scholar working on Otorhinolaryngology, Oncology and Surgery. According to data from OpenAlex, David Schuller has authored 19 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Otorhinolaryngology, 11 papers in Oncology and 6 papers in Surgery. Recurrent topics in David Schuller's work include Head and Neck Cancer Studies (11 papers), Salivary Gland Tumors Diagnosis and Treatment (4 papers) and Lung Cancer Treatments and Mutations (3 papers). David Schuller is often cited by papers focused on Head and Neck Cancer Studies (11 papers), Salivary Gland Tumors Diagnosis and Treatment (4 papers) and Lung Cancer Treatments and Mutations (3 papers). David Schuller collaborates with scholars based in United States, Switzerland and India. David Schuller's co-authors include Gregory A. Grant, Leonard Banaszak, Kris R. Jatana, James C. Lang, Amit Agrawal, Liying Yang, Priya Balasubramanian, Jeffrey J. Chalmers, Maciej Zborowski and J.C. Grecula and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

David Schuller

19 papers receiving 618 citations

Peers

David Schuller

MB

ONCOL

MC

BE

PRM

Li‐Ping Ge China

Chunyan Li China

Kyungmi Yang South Korea

Rom Keshet Israel

Á. Rojas United Kingdom

Marcelle Guichard France

Xiaohui Miao China

Kyeongmin Kim South Korea

Orlando J. Martelo United States

T. L. Loo United States

Li‐Ping Ge China

David Schuller

343 ×1.4

MB

253 ×1.1

ONCOL

34 ×0.2

MC

51 ×0.4

BE

171 ×1.6

PRM

Citations per year, relative to David Schuller David Schuller (= 1×) peers Li‐Ping Ge

Countries citing papers authored by David Schuller

Since Specialization

Citations

This map shows the geographic impact of David Schuller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Schuller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Schuller more than expected).

Fields of papers citing papers by David Schuller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Schuller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Schuller. The network helps show where David Schuller may publish in the future.

Co-authorship network of co-authors of David Schuller

This figure shows the co-authorship network connecting the top 25 collaborators of David Schuller. A scholar is included among the top collaborators of David Schuller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Schuller. David Schuller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

1.

Milano, Shawn K., Qingqiu Huang, Sekar Ramachandran, et al.. (2021). New insights into the molecular mechanisms of glutaminase C inhibitors in cancer cells using serial room temperature crystallography. Journal of Biological Chemistry. 298(2). 101535–101535. 24 indexed citations

2.

Patel, Krupal, Daniel Martin, Songzhu Zhao, et al.. (2020). Impact of age and comorbidity on survival among patients with oral cavity squamous cell carcinoma. Head & Neck. 43(1). 268–277. 3 indexed citations

3.

Balasubramanian, Priya, Liying Yang, James C. Lang, et al.. (2009). Confocal Images of Circulating Tumor Cells Obtained Using a Methodology and Technology That Removes Normal Cells. Molecular Pharmaceutics. 6(5). 1402–1408. 45 indexed citations

4.

Yang, Liying, James C. Lang, Priya Balasubramanian, et al.. (2008). Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells. Biotechnology and Bioengineering. 102(2). 521–534. 165 indexed citations

5.

Civantos, Francisco, Robert P. Zitsch, David Schuller, et al.. (2006). S009 Sentinel Lymph Node Biopsy for Oral Cancer: A Multi-institutional Validation Trial. Archives of Otolaryngology - Head and Neck Surgery. 132(8). 839–839. 1 indexed citations

6.

Wang, Dian, J.C. Grecula, R. Gahbauer, et al.. (2006). p16 gene alterations in locally advanced squamous cell carcinoma of the head and neck. Oncology Reports. 15(3). 661–5. 9 indexed citations

7.

Rhoades, Chris A., Eric H. Kraut, David Schuller, et al.. (2004). Phase I and II study of OSI-774 and docetaxel in squamous cell carcinoma of the head and neck (SCCHN). Journal of Clinical Oncology. 22(14_suppl). 5541–5541. 3 indexed citations

8.

Rhoades, Chris A., Eric H. Kraut, David Schuller, et al.. (2004). Phase I and II study of OSI-774 and docetaxel in squamous cell carcinoma of the head and neck (SCCHN). Journal of Clinical Oncology. 22(14_suppl). 5541–5541. 10 indexed citations

9.

Nag, Subir, Douglas Tippin, J.C. Grecula, & David Schuller. (2003). Intraoperative high-dose-rate brachytherapy for paranasal sinus tumors. International Journal of Radiation Oncology*Biology*Physics. 58(1). 155–160. 12 indexed citations

10.

Forastiere, A., H Goepfert, Don R. Goffinet, et al.. (1998). NCCN practice guidelines for head and neck cancer. National Comprehensive Cancer Network.. PubMed. 12(7A). 39–147. 21 indexed citations

11.

Nag, Sukriti, et al.. (1997). IORT Using Electron Beam or HDR Brachytherapy for Previously Unirradiated Head and Neck Cancers. Frontiers of radiation therapy and oncology. 31. 112–116. 11 indexed citations

12.

Helfenstein, Ulrich, et al.. (1996). Action Profiles of Predictors of Death and Survival Time in Stage I Malignant Melanoma. Dermatology. 192(1). 1–7. 5 indexed citations

13.

Nag, Subir, et al.. (1996). Pilot study of intraoperative high dose rate brachytherapy for head and neck cancer. Radiotherapy and Oncology. 41(2). 125–130. 26 indexed citations

14.

Smith, Roy E., Danika L. Lew, Gladys Rodriguez, et al.. (1996). Evaluation of topotecan in patients with recurrent for metastatic squamous cell carcinoma of the head and neck. Investigational New Drugs. 14(4). 403–407. 15 indexed citations

15.

Giri, P.G. Shankar, M. Leblanc, Muhyi Al‐Sarraf, et al.. (1996). 8 Improved survival with chemotherapy and radiation therapy versus radiation therapy alone in advanced nasopharyngeal cancer. Preliminary results of an intergroup randomized trial. Int 0099, SWOG 8892, RTOG 8817, ECOG 2388. International Journal of Radiation Oncology*Biology*Physics. 36(1). 162–162. 9 indexed citations

16.

Schuller, David, Gregory A. Grant, & Leonard Banaszak. (1995). The allosteric ligand site in the Vmax-type cooperative enzyme phosphoglycerate dehydrogenase. Nature Structural Biology. 2(1). 69–76. 218 indexed citations

17.

Weymuller, Ernest A., Roy R. Casiano, George E. Laramore, et al.. (1994). Surgical Reporting Instrument Designed to Improve Outcome Data in Head and Neck Cancer Trials. Annals of Otology Rhinology & Laryngology. 103(7). 499–509. 11 indexed citations

18.

Taylor, Sarah A., Jacqueline Benedetti, David Schuller, et al.. (1993). Phase II trial of piroxantrone in patients with recurrent and metastatic squamous cell carcinoma of the head and neck. Investigational New Drugs. 11(2-3). 227–229. 2 indexed citations

19.

Lill, Helmut, et al.. (1993). A new immunoassay for soluble fibrin enables a more sensitive detection of the activation state of blood coagulation in vivo.. PubMed. 4(1). 97–102. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact